The Valley Desk

NCT03763149 · Interventional trial

A Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and Lymphomas

Overall registry status Completed

Phase 1

Conditions Advanced Malignancies

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov